viernes, 20 de noviembre de 2026

Sugar from gut bacterium helps burn harmful visceral fat

https://www.news-medical.net/news/20261119/Sugar-from-gut-bacterium-helps-burn-harmful-visceral-fat.aspx Scientists have discovered that a sugar produced by a gut bacterium can increase energy burning in visceral fat-the harmful fat that accumulates around internal organs-while reducing weight gain and improving metabolic health, offering a potential new approach to tackling obesity. Their findings come as concerns over rising obesity rates continue to grow, with half of the world's population expected to be overweight or obese by 2035. In Singapore, over 12 per cent of the country's population is living with obesity. In the study, published in Cell Host & Microbe, researchers from Duke-NUS Medical School and Duke University School of Medicine identified a bacterium, Clostridium immunis (C. immunis), which lives in the gut. The team discovered that C. immunis produces a sugar molecule known as an exopolysaccharide (EPS). This sugar requires a small chemical group called phosphocholine for activity. This phosphocholine-modified sugar-like an "on switch"-catalyses the reduction of weight gain and visceral fat, which is closely linked to metabolic diseases such as type 2 diabetes and cardiovascular disease.

Menopause relief without hormones? Here’s what experts say actually works

From targeted medications and clinical hypnosis to dietary changes and herbal supplements, European menopause experts examine which hormone-free treatments hold the strongest scientific evidence for symptom relief. https://www.news-medical.net/news/20261119/Menopause-relief-without-hormones-Heree28099s-what-experts-say-actually-works.aspx In a recent consensus statement published in the journal Gynecological Endocrinology, an international expert panel from the European Society of Gynecology (ESG) reviewed evidence on non-hormonal interventions to manage menopausal symptoms in women with medical contraindications to, or who prefer not to use, menopausal hormone therapy (MHT).

Headaches linked to 70% higher odds of hearing loss in later life

https://www.news-medical.net/news/20261119/Headaches-linked-to-7025-higher-odds-of-hearing-loss-in-later-life.aspx Could a common neurological symptom offer clues about hearing health as we age? Researchers examine seven years of health survey data to explore a potential connection with implications for community hearing screening. In a study published in the journal BMC Public Health, researchers analyzed long-term health data from China and South Korea to examine whether self-reported headaches are associated with self-reported hearing loss in later life. Scientists from Guangzhou University of Chinese Medicine and its First Affiliated Hospital, the Lingnan Institute of Otolaryngology, and Guangdong Second Traditional Chinese Medicine Hospital in Guangzhou, China, conducted the research.

Continuing advanced therapies before surgery linked to fewer Crohn's complications

https://www.news-medical.net/news/20261119/Continuing-advanced-therapies-before-surgery-linked-to-fewer-Crohns-complications.aspx Patients with Crohn's disease who continue advanced therapies, including biologics and small-molecule drugs, in the months before elective colorectal surgery may have a lower risk of two postoperative complications: anastomotic leak and organ space surgical site infection, according to a study published in the Journal of the American College of Surgeons. These findings challenge previous thoughts that immunosuppressive therapies should be stopped before surgery due to concerns about postoperative complications. In contrast, advanced therapy use was associated with improved outcomes and lower risk of anastomotic leak and organ space surgical site infection, a feared complication of colorectal surgery.

Exposing hidden immune vulnerabilities in KRAS-mutant non-small cell lung cancer

https://www.news-medical.net/news/20261120/Exposing-hidden-immune-vulnerabilities-in-KRAS-mutant-non-small-cell-lung-cancer.aspx In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and kill. MYC is a protein that is known to malfunction in cancer, allowing cells to grow and divide uncontrollably. However, until recently, researchers have struggled to find a way to target MYC. The experimental drug OMO-103 was designed to inhibit MYC and is already being tested with patients in clinical trials. The new research, to be presented on Friday at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, shows that OMO-103 also seems to enable white blood cells to find and destroy cancer cells.

Most Read Cancer Science & Oncogenesis (+...)

https://read.qxmd.com/collection/1133?ecd=wnl_readmost_261120

Large NIH-supported study identifies key underlying pathways in endometriosis Findings shed light on genetic associations and mechanisms driving complex disorder.

https://www.nih.gov/news-events/news-releases/large-nih-supported-study-identifies-key-underlying-pathways-endometriosis U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News National Institutes of Health For Immediate Release: Friday, November 20, 2026 CONTACT: NIH Office of Communications, LARGE NIH-SUPPORTED STUDY IDENTIFIES KEY UNDERLYING PATHWAYS IN ENDOMETRIOSIS Findings shed light on genetic associations and mechanisms driving complex disorder In a large, international study analyzing data from over 1 million people, researchers supported by the National Institutes of Health (NIH) identified multiple genomic regions, associations, and pathways underlying endometriosis, a debilitating, chronic condition in which tissue similar to the lining of the uterus grows in other places in the body. Endometriosis affects up to 1 in 10 women worldwide, it can lead to severe pain and fertility challenges, and it may be associated with risk for other diseases. The findings, published in Nature Genetics, provide insights that could someday lead to studies on potential targets for therapeutic interventions for this complex condition. “The findings from this large multi-ancestry study provide a wealth of information on the genetic underpinnings of endometriosis, a severely painful condition for which NIH is actively pursuing a cure,” said John Gaitanis, M.D., director of NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which supported the study. “A greater understanding will help us take steps toward developing diagnostic tools and treatments to address this devastating disease.” Despite its prevalence, researchers still need to learn more about why and how endometriosis develops. Researchers have previously used genome-wide association studies to look for genes and pathways linked with endometriosis. However, these studies have primarily included populations with European ancestry, with some East Asian populations at a smaller scale. In the new study, the research team conducted a meta-analysis of endometriosis spanning 14 biobanks worldwide, representing over 1 million participants. Over 30% of those were of non-European ancestry. The researchers used a phenotyping approach, looking at a wide variety of cases of endometriosis, and looked for genetic associations and risk factors shared with other diseases. They also conducted further “multi-omic” analyses, looking at several kinds of biological data to identify genes associated with endometriosis. The researchers detected 58 genomic regions linked to endometriosis, including 27 that had not been recognized before. By studying people of African ancestry and Admixed-American ancestry (or groups with mixed North, Central, and South American heritage), the team found genetic links to endometriosis that had not been seen before. They found that endometriosis shares genetic links with 135 other health conditions or traits. Finally, through the multi-omic analyses, they identified 314 genes that may be associated with endometriosis. Together, these findings offer a bigger picture of endometriosis than was previously available and could lead to studies looking at the function of the mechanisms driving the disease. “By studying many types of biological data across people with different ancestries, we were able to increase our understanding of how endometriosis develops and affects the body,” said Shefali Setia-Verma, Ph.D., senior author of the study and Assistant Professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. “Our findings will help guide future research that could eventually lead to better diagnosis, personalized risk assessment, and treatments that target the disease.” About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov. NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office ### This NIH News Release is available online at: